Venugopal P V, Venugopal T V
Institute of Microbiology and Pathology, Madras Medical College, India.
Australas J Dermatol. 1993;34(1):27-9. doi: 10.1111/j.1440-0960.1993.tb00844.x.
Ten patients with eumycetoma were treated with oral ketoconazole in the dosage of 400mg/day for 8 to 24 months. In eight cases the foot was affected: four were due to Madurella mycetomatis and one each due to M grisea, Pyrenochaeta romeroi, Acremonium kiliense and A falciorme. One mycetoma which affected the back and perineum was due to A kiliense, and one case presented with multiple sebaceous cysts and the scalp and M mycetomatis was isolated from the lesion. Clinical and laboratory tests showed excellent tolerance to the drug, with no adverse reactions. Complete cure was obtained in six patients and two showed good responses. The cured patients were followed up for a period ranging from three months to two years without any evidence of recurrence.
10例足菌肿患者接受口服酮康唑治疗,剂量为400mg/天,疗程8至24个月。8例足部受累:4例由马杜拉足肿菌引起,1例分别由灰霉菌、罗梅罗拟茎点霉、基利枝顶孢和镰状枝顶孢引起。1例背部和会阴受累的足菌肿由基利枝顶孢引起,1例表现为多发性皮脂腺囊肿,从病变处分离出头皮和马杜拉足肿菌。临床和实验室检查显示对该药物耐受性良好,无不良反应。6例患者完全治愈,2例反应良好。对治愈的患者进行了3个月至2年的随访,无复发迹象。